Analysts who follow bluebird bio Inc (BLUE) on average expect it to rise 238.90% over the next twelve months. Those same analysts give the stock an average rating of Buy.
That average rating earns BLUE an Analyst Ranking of 18, which means it ranks higher than 18 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating BLUE a Buy today. Find out what this means to you and get the rest of the rankings on BLUE!
Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.
InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.
What's Happening With bluebird bio Inc Stock Today?
bluebird bio Inc (BLUE) stock is trading at $1.36 as of 12:39 PM on Monday, Mar 25, a loss of -$0.01, or -1.09% from the previous closing price of $1.37. The stock has traded between $1.34 and $1.42 so far today. Volume today is low. So far 2,390,493 shares have traded compared to average volume of 10,080,789 shares.
Click Here to get the full Stock Report for bluebird bio Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
